Showing results (1691-1700 of 2,527) with videos related to

Sort By:
Pageof 253
Plos One|September 14, 2011
Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancerSomaira Nowsheen, James A Bonner, Albert F Lobuglio, et al.
AJR. American Journal of Roentgenology|October 1, 1992
Regional lymph node metastases in carcinoma of the left side of the colon and rectum: CT demonstrationC A Granfield, C Charnsangavej, R A Dubrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
Ethiodized oil emulsion 13 in computed tomography of hepatomaJ P Dutcher, P J Haney, N O Whitley, et al.
JIMD Reports|November 6, 2013
Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndromeKathleen A Delaney, Kyle R Rudser, Brianna D Yund, et al.
Molecular Genetics and Metabolism|December 26, 2013
Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndromeAlia Ahmed, Chester B Whitley, Renee Cooksley, et al.
Annals of Clinical Microbiology and Antimicrobials|September 13, 2017
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective studyWhitley M Yi, Kelly E Schoeppler, Jaclyn Jaeger, et al.
JIMD Reports|September 10, 2019
Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study populationChristine Haller, Wenjie Song, Tricia Cimms, et al.
Heliyon|February 11, 2025
Creation and evaluation of a gender diversity focused cultural competency training for phlebotomists: Study protocol for a randomized controlled trialHenrietta Maku, Christina C Pierre, Dina N Greene, et al.
Movement Disorders Clinical Practice|January 4, 2025
An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated DystoniaAndres Deik, Whitley Aamodt, Christina Cadet, et al.
Multiple Sclerosis and Related Disorders|September 16, 2023
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort studyHarry Jin, Caroline Geiger, Nikki Jessop, et al.
Pageof 253